The global biopsy devices market was valued at $2,728 million in 2018 and is expected to reach $4,310 million by 2026


You May Also Like

Coherus BioSciences Reports Fourth Quarter and Full Year 2017 Financial Results

REDWOOD CITY, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

Stemline Therapeutics Announces Proposed Public Offering of Common Stock

NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...